Quick Answer
Mosaic ImmunoEngineering Inc. reported Stockholders Equity of -$6.79 million for fiscal year 2024.
Mosaic ImmunoEngineering Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$6.79M | -15.6% |
| 2023 | -$5.87M | -20.2% |
| 2022 | -$4.88M | -74.5% |
| 2021 | -$2.80M | -562.4% |
| 2020 | -$422.5K | -94217.2% |
| 2020 | -$448.00 | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $1.70M | -32.0% |
| 2018 | $2.50M | -32.6% |
| 2017 | $3.70M | -1.2% |
| 2016 | $3.75M | -25.2% |
| 2015 | $5.02M | -23.0% |
| 2014 | $6.51M | -20.0% |
| 2013 | $8.14M | +14.8% |
| 2012 | $7.09M | -41.0% |
| 2011 | $12.02M | -48.5% |
| 2010 | $23.35M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.31M | -10.1% | -2.3% |
| June 30, 2025 | -$7.14M | -10.7% | -2.5% |
| March 31, 2025 | -$6.97M | -13.2% | -2.7% |
| December 31, 2024 | -$6.79M | -15.6% | -2.3% |
| September 30, 2024 | -$6.64M | -18.9% | -2.9% |
| June 30, 2024 | -$6.45M | -22.7% | -4.8% |
| March 31, 2024 | -$6.15M | -16.6% | -4.8% |
| December 31, 2023 | -$5.87M | -20.2% | -5.2% |
- Mosaic ImmunoEngineering Inc. showed a decrease of -15.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2024 period, Mosaic ImmunoEngineering Inc.’s stockholders equity has declined by 129.1% (from $23.35 million to -$6.79 million).
- The most recent figure is from Mosaic ImmunoEngineering Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: